97342 ⎘
Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THEREOF FOR THE TREATMENT OF DISEASES
#2MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERINE ONCOPROTECTION, AND OVARIAN RESERVE AND UTERINE PRESERVATION
#3GENETICALLY ENCODED MULTIMERIC NANOPARTICLES FOR PHYSICAL ANALYSIS OF THE CELL INTERIOR
#4METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#5DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#6BINDING MOLECULES FOR BCMA AND CD3
#7A DEGRON FOR REGULATING PROTEIN EXPRESSION AND METHODS THEREOF
#8MODULATORS OF MESOTHELIAL ECM MOVEMENT
#9D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#10COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS
#11HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS
#12RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2
#13UTILIZATION OF GENE TARGETING ANTIBODY FUSION PROTEINS TO PERFORM IN VIVO THERAPEUTIC GENE EDITING
#14PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS
#15PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS
#16ANTIGEN BINDING FRAGMENTS CONJUGATED TO A PLURALITY OF FC ISOTYPES AND SUBCLASSES
#17D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#18COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING FIBROSIS
#19USE OF CXCL14
#20ERYTHROCYTE-BINDING THERAPEUTICS
#21CELL TARGETING COMPOSITIONS AND METHODS
#22RECOMBINANT PROTEIN OF GPER
#23FUSION PROTEIN
#24METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES
#25CORONAVIRUS FUSION PROTEIN
#26METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#27TREATMENT OF FIBROSIS
#28Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
#29PROTEIN SCREENING AND DETECTION METHOD
#30INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS
#31ERYTHROCYTE-BINDING THERAPEUTICS
#32USE OF A FUSION PROTEIN FOR INDUCING GENETIC MODIFICATIONS BY TARGETED MEIOTIC RECOMBINATION
#33HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION
#34METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#35REDIRECTING RISC FOR RNA EDITING
#36PROGRAMMABLE CAS9-RECOMBINASE FUSION PROTEINS AND USES THEREOF
#37AUTOTRANSPORTER SYSTEM
#38BINDING PROTEINS RECOGNIZING HA-2 ANTIGEN AND USES THEREOF
#39PROTEIN PROSTHESES FOR MITOCHONDRIAL DISEASES OR CONDITIONS
#40Nucleic Acids That Manipulate Immune Pathways
#41CHIMERIC PHAGOCYTIC RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
#42HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION
#43Methods and products for genetic engineering
#44IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF
#45Methods and products for genetic engineering
#46MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR OVARIAN AND UTERINE ONCOPROTECTION, AND OVARIAN RESERVE AND UTERINE PRESERVATION
#47Exosome-targeted DNA vaccine
#48CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS
#49Preparation of therapeutic exosomes using membrane proteins
#50METHODS AND COMPOSITIONS
#51METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA
#52METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA
#53ENABLING CHOLESTEROL CATABOLISM IN HUMAN CELLS
#54ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF
#55INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES
#56VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS
#57CAR-Treg-Based Therapies Targeting Myelin Oligodendrocyte Glycoprotein (MOG) for Treating Neurodegenerative Diseases
#58RECOMBINANT POLYPEPTIDES FOR PROGRAMMING EXTRACELLULAR VESICLES
#59RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
#60METHODS AND COMPOSITIONS FOR SYNTHESIZING IMPROVED SILK FIBERS
#61MULTIMERS, TETRAMERS & OCTAMERS
#62RECOMBINANT FIBCD1 AND USE THEROF IN THE TREATMENT OF MUSCLE ATROPHY
#63RECOMBINANT BACTERIA FOR USE AS A VACCINE TO PREVENT COVID19 INFECTION
#64ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS
#65ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF
#66D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#67NOVEL METHODS FOR CREATING ALPHA-N-METHYLATED POLYPEPTIDES
#68Compositions, methods, and systems for orally administrable affinity-based protein
#69SWI/SNF FAMILY CHROMATIN REMODELING COMPLEXES AND USES THEREOF
#70REGULATABLE CHIMERIC ANTIGEN RECEPTOR
#71COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS
#72RECOMBINANT NEURAMINIDASE AND USES THEREOF
#73NUCLEIC ACID CONSTRUCT THAT ENCODES CHIMERIC RHODOPSIN
#74Binding molecules for BCMA and CD3
#75MULTIMERIC PROTEIN DOMAINS FOR MULTIFUNCTIONALITY AND ENHANCED SECRETION OF THERAPEUTIC PROTEINS
#76PEPTIDE-LOADED CARRIER SYSTEMS AND USES THEREOF
#77SYSTEMS AND METHODS FOR GENE THERAPY VIA ADMINISTRATION OF GENETICALLY MODIFIED VIRAL VECTORS
#78BINDING MOLECULES FOR BCMA AND CD3
#79Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
#80MEMBRANE PROTEIN SCAFFOLDS FOR EXOSOME ENGINEERING
#81RECOMBINANT DEAMIDATED GLIADIN POLYPEPTIDE ANTIGEN, RECOMBINANT ANTIGEN-EXPRESSING GENE, RECOMBINANT EXPRESSION VECTOR, AND PREPARATION METHOD AND APPLICATION THEREOF
#82Exosome-targeted DNA vaccine
#83Variant ICOS ligand immunomodulatory proteins and related compositions and methods
#84Binding molecules for BCMA and CD3
#85Anti-factor IX padua antibodies
#86N- and C-terminal tandem tag system for purification
#87POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER
#88MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THEREOF FOR THE TREATMENT OF DISEASES
#89METHODS FOR AGGREGATION OF PROTEINS
#90LPL-GPIHBP1 FUSION POLYPEPTIDES
#91D-domain containing polypeptides and uses thereof
#92D-domain containing polypeptides and uses thereof
#93Compositions and methods for treating or preventing fibrosis
#94GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE
#95Methods for the production of therapeutic, diagnostic, or research antibodies
#96Methods and products for genetic engineering
#97BIOPHARMACEUTICAL AGENTS FOR USE IN REDUCING LIPID CONTENT IN CELLS
#98RECOMBINANT GRP94 CHAPERONES AND METHODS OF USING THE SAME TO MODULATE GLYCOSYLATION IN FUSION PROTEINS
#99Erythrocyte-binding therapeutics
#100DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#101Chimeric antigen receptor and application thereof
#102Treatment of fibrosis
#103Compositions, methods, and systems for orally administrable affinity-based protein
#104CELL SORTING SYSTEMS AND METHODS OF USE
#105LEUCINE ZIPPER-BASED COMPOSITIONS AND METHODS OF USE
#106Humanized DR4 antibody gene having apoptosis-inducing activity and dual-acting chimeric antigen receptor T cell or natural killer cell therapeutic agent using same
#107Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#108Interleukin-2 muteins for the expansion of T-regulatory cells
#109Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#110Multi Component Detection
#111Erythrocyte-binding therapeutics
#112SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS
#113DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#114Protease activity profiling via programmable phage display of comprehensive proteome-scale peptide libraries
#115RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci
#116GENOME ENGINEERING WITH CRISPR-CAS SYSTEMS IN EUKARYOTES
#117Genome engineering with type I CRISPR systems in eukaryotic cells
#118Split superantigens and their use for immunotherapy
#119ANTIGEN BINDING FRAGMENTS CONJUGATED TO A PLURALITY OF FC ISOTYPES AND SUBCLASSES
#120ANTIGEN BINDING PROTEINS
#121VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS
#122Virus-like particle (VLP) based small molecule-protein interaction trap
#123P97-IDS fusion proteins
#124Vector construct
#125Recombinant fusion protein of BAF57 and uses thereof
#126A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES
#127De novo binding domain containing polypeptides and uses thereof
#128Preparation of therapeutic exosomes using membrane proteins
#129NUCLEIC ACIDS THAT MANIPULATE IMMUNE PATHWAYS
#130Compostions and methods for enabling cholesterol catabolism in human cells
#131Evaluation System for Therapeutic Drug for Genetic Kidney Disorder Alport Syndrome
#132FUSION POLYPEPTIDE AND METHOD FOR PRODUCING FUSION POLYPEPTIDE
#133Multiplex Guide RNAS
#134FUSION PROTEIN
#135NOVEL PROTEINS AND USE THEREOF
#136Antigen-specific tolerance and compositions for induction of same
#137CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
#138Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#139Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation
#140Methods and compositions for synthesizing improved silk fibers
#141Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy
#142Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
#143Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
#144Light-gated signaling modulation
#145COMPOSITIONS AND METHODS RELATING TO MYOMIXER-PROMOTED MUSCLE CELL FUSION
#146Erythrocyte-binding therapeutics
#147Zika as a cell penetrating peptide for delivery to the brain
#148Programmable CAS9-recombinase fusion proteins and uses thereof
#149Amino acid sequence presenting fusion polypeptide and its use
#150Virus-like particle (VLP) based small molecule-protein interaction trap
#151DNA polymerase variant and application thereof
#152Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
#153CELL EXPRESSING CAR AND GPCR
#154Protein screening and detection method
#155Regulatable chimeric antigen receptor
#156Cell-associated secretion-enhancing fusion proteins
#157TARGETABLE PROTEINS FOR EPIGENETIC MODIFICATION AND METHODS FOR USE THEREOF
#158Multimers, tetramers and octamers
#159Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds
#160METHODS AND COMPOSITIONS RELATED TO ANTIGEN PRESENTING PROTEINS
#161Anti-factor IX Padua antibodies
#162Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#163Selective Bfl-1 peptides
#164Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#165Methods of transcription activator like effector assembly
#166Botulinum neurotoxin and its derivatives
#167Polypeptide nano-bubbles and preparation method and application thereof
#168Genetically-mutated bacterial strain for detecting estrogenic compound and method for detecting estrogenic compound using the same
#169Methods of making gels and films using curli nanofibers
#170Compositions and methods for anti-staphylococcal biologic agents
#171MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF
#172Preparation of therapeutic exosomes using membrane proteins
#173Highly sensitive and specific luciferase based reporter assay for antigen detection
#174Methods for the production of therapeutic, diagnostic, or research antibodies
#175Flag tagged CD19-CAR-T cells
#176Preparation of therapeutic exosomes using membrane proteins
#177Methods and products for genetic engineering
#178COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS
#179Protein prostheses for mitochondrial diseases or conditions
#180Treatment of fibrosis with interleukin-11 antibody
#181ANTIBODY WHICH SPECIFICALLY BINDS TO HUMAN CRTH2
#182Treatment of fibrosis with interleukin-11 receptor alpha antibody
#183Treatment of fibrosis with interleukin-11 receptor alpha antibody
#184NKG2D decoys
#185Treatment of fibrosis with interleukin-11 antibody
#186Treatment of fibrosis with interleukin-11 receptor alpha antibody
#187Treatment of fibrosis with IL-11 receptor alpha antibody
#188Treatment of fibrosis with Interleukin-11 receptor alpha antibody
#189Treatment of fibrosis with interleukin-11 receptor alpha antibody
#190Treatment of fibrosis with interleukin-11 antibody
#191Treatment of fibrosis with interleukin-11 antibody
#192Treatment of fibrosis with interleukin-11 antibody
#193Treatment of fibrosis with interleukin-11 antibody
#194ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#195Compounds for treating neurodegenerative proteinopathies
#196Genome engineering with Type I CRISPR systems in eukaryotic cells
#197Interleukin-2 muteins for the expansion of T-regulatory cells
#198Heat-inducible self-assembling protein domains
#199Methods and compositions for synthesizing improved silk fibers
#200Human CD30 Ligand Antigen Binding Proteins
#201Methods and compositions for synthesizing improved silk fibers
#202Inhibin analogs
#203Fusion protein crystal comprising a moiety
#204De novo binding domain containing polypeptides and uses thereof
#205De novo binding domain containing polypeptides and uses thereof
#206Methods and compositions for cells expressing a chimeric intracellular signaling molecule
#207Interleukin-2 muteins for the expansion of T-regulatory cells
#208Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, DNA, and vector
#209POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER
#210Antigen-specific tolerance and compositions for induction of same
#211Compositions for generation of immune tolerance to specific antigens
#212Compositions for inducing antigen-specific tolerance
#213CELLULAR EXPRESSION MODEL OF TAU AGGREGATION
#214Libraries of modified fibronectin type III tenth domain-containing polypeptides
#215Humanized anti-CD19 antibody and use thereof with chimeric antigen receptor
#216Sensor systems for target ligands and uses thereof
#217PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment
#218Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
#219Targeting GIV-GEF-GI signaling for treating diverse diseases
#220Erythrocyte-binding therapeutics
#221PROTEIN EXPRESSION ENHANCING POLYPEPTIDES
#222Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereof
#223Virus-like particle (VLP) based small molecule-protein interaction trap
#224Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#225Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#226High affinity antibody antagonists of interleukin-13 receptor alpha 1
#227Method of highly expressing target protein from plant using RbcS fusion protein and method of preparing composition for oral administration of medical protein using target protein expression plant body
#228Compositions and cell-based methods for monitoring the activity of a Dengue Virus protease
#229Compositions comprising GRIM-19 therapeutics and methods of use
#230Feline bitter taste receptors and methods
#231Systems for Factor VIII Processing and Methods Thereof
#232Multi component detection
#233P97-IDS fusion proteins
#234COMPOSITIONS AND METHODS FOR IDENTIFYING ENZYME MODULATORS OR INHIBITORS
#235Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
#236Immunity inducer
#237Interleukin-2 muteins for the expansion of T-regulatory cells
#238Covalent tethering of functional groups to proteins and substrates therefor
#239Methods and compositions for synthesizing improved silk fibers
#240Porous membrane-binding peptides
#241Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds
#242Interleukin-2 muteins for the expansion of T-regulatory cells
#243Erythrocyte-binding therapeutics
#244Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#245Peptides derived from NCAPG2 and their use
#246Methods for identifying and isolating cells expressing a polypeptide
#247High affinity antibody antagonists of interleukin-13 receptor alpha 1
#248Methods for reducing immune responses
#249Compositions for inducing antigen-specific tolerance
#250Methods for induction of antigen-specific immune tolerance
#251Compositions for generating immune tolerance by targeting erythrocytes
#252Alternative splicing variant of OATP1B3 mRNA
#253Means and methods for detecting activated MALT1
#254Multiplex guide RNAs
#255Methods of transcription activator like effector assembly
#256METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1
#257Nucleic acid sequence segment for enhancing protein expression
#258Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy
#259Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#260Feline bitter taste receptors and methods
#261Reagents and methods for treating dental disease
#262Amino acid sequence presenting fusion polypeptide and its use
#263Antibody specifically binding to insulin-like growth factor-1
#264Interference peptides and use thereof
#265Compositions and methods for identifying enzyme and transport protein inhibitors
#266Human CD30 ligand antigen binding proteins
#267Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases
#268IMMUNOGENIC COMPOSITION COMPRISING ALPHA-HEMOLYSIN OLIGOPEPTIDES
#269Compounds for treating neurodegenerative proteinopathies
#270Bioreversible boronates for delivery of molecules into cells
#271Gene from tidal flat metagenome and a novel protein displaying both phospholipase and lipase activities
#272Method for preparing C1q recombinant protein
#273Methods for identifying and isolating cells expressing a polypeptide
#274Asparaginase and treating diseases associated with asparagine dependence
#275Protein expression enhancing polypeptides
#276Recombinant TNF ligand family member polypeptides with antibody binding domain and uses therefor
#277Diagnostic method for detecting an autoimmune disease
#278Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#279Compounds and methods for modulating pharmacokinetics
#280Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins
#281Conformation-stabilized TRAP antigens
#282Endoglucanase variants
#283Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
#284ADAPTER MOLECULE CAPABLE OF REVERSIBLY EQUIPPING A FUSION PROTEIN CARRYING AN OLIGOHISTIDINE AFFINITY TAG WITH A FURTHER AFFINITY TAG AND METHODS OF USING THE SAME
#285BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology
#286AKT ligands and polynucleotides encoding AKT ligands
#287Wnt compositions and therapeutic uses of such compositions
#288Nitration shielding peptides and methods of use thereof
#289Reagents and methods for treating dental disease
#290Phage display using contranslational translocation of fusion polypeptides
#291Anti-tumor necrosis factor-alpha agents and uses thereof
#292Multi component antibody based detection technology
#293Binding molecules for BCMA and CD3
#294RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
#295Detecting inclusion body myositis
#296Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
#297Transmembrane protein as biosensors
#298Erythrocyte-binding therapeutics
#299Binding molecules for BCMA and CD3
#300Expression vectors for cell-surface expression of polypeptides comprising a transmembrane domain of glycophorin A